id	sid	tid	token	lemma	pos
cajgh-110	1	1	study	study	NOUN
cajgh-110	1	2	of	of	ADP
cajgh-110	1	3	the	the	DET
cajgh-110	1	4	erythropoiesis	erythropoiesis	NOUN
cajgh-110	1	5	activity	activity	NOUN
cajgh-110	1	6	of	of	ADP
cajgh-110	1	7	nano	nano	NOUN
cajgh-110	1	8	-	-	PUNCT
cajgh-110	1	9	encapsulated	encapsulate	VERB
cajgh-110	1	10	forms	form	NOUN
cajgh-110	1	11	of	of	ADP
cajgh-110	1	12	erythropoietin	erythropoietin	ADJ
cajgh-110	1	13	new	new	ADJ
cajgh-110	1	14	articles	article	NOUN
cajgh-110	1	15	in	in	ADP
cajgh-110	1	16	this	this	DET
cajgh-110	1	17	journal	journal	NOUN
cajgh-110	1	18	are	be	AUX
cajgh-110	1	19	licensed	license	VERB
cajgh-110	1	20	under	under	ADP
cajgh-110	1	21	a	a	DET
cajgh-110	1	22	creative	creative	ADJ
cajgh-110	1	23	commons	common	NOUN
cajgh-110	1	24	attribution	attribution	NOUN
cajgh-110	1	25	3.0	3.0	NUM
cajgh-110	1	26	united	unite	VERB
cajgh-110	1	27	states	states	PROPN
cajgh-110	1	28	license	license	NOUN
cajgh-110	1	29	.	.	PUNCT
cajgh-110	2	1	this	this	DET
cajgh-110	2	2	journal	journal	NOUN
cajgh-110	2	3	is	be	AUX
cajgh-110	2	4	published	publish	VERB
cajgh-110	2	5	by	by	ADP
cajgh-110	2	6	theuniversity	theuniversity	NOUN
cajgh-110	2	7	library	library	NOUN
cajgh-110	2	8	system	system	NOUN
cajgh-110	2	9	of	of	ADP
cajgh-110	2	10	the	the	DET
cajgh-110	2	11	university	university	PROPN
cajgh-110	2	12	of	of	ADP
cajgh-110	2	13	pittsburgh	pittsburgh	PROPN
cajgh-110	2	14	as	as	ADP
cajgh-110	2	15	part	part	NOUN
cajgh-110	2	16	of	of	ADP
cajgh-110	2	17	its	its	PRON
cajgh-110	2	18	d	d	NOUN
cajgh-110	2	19	-	-	PUNCT
cajgh-110	2	20	scribe	scribe	VERB
cajgh-110	2	21	digital	digital	ADJ
cajgh-110	2	22	publishing	publishing	NOUN
cajgh-110	2	23	program	program	NOUN
cajgh-110	2	24	and	and	CCONJ
cajgh-110	2	25	is	be	AUX
cajgh-110	2	26	cosponsored	cosponsor	VERB
cajgh-110	2	27	by	by	ADP
cajgh-110	2	28	the	the	DET
cajgh-110	2	29	university	university	PROPN
cajgh-110	2	30	of	of	ADP
cajgh-110	2	31	pittsburgh	pittsburgh	PROPN
cajgh-110	2	32	press	press	NOUN
cajgh-110	2	33	.	.	PUNCT
cajgh-110	3	1	study	study	NOUN
cajgh-110	3	2	of	of	ADP
cajgh-110	3	3	the	the	DET
cajgh-110	3	4	erythropoiesis	erythropoiesis	NOUN
cajgh-110	3	5	activity	activity	NOUN
cajgh-110	3	6	of	of	ADP
cajgh-110	3	7	nano	nano	NOUN
cajgh-110	3	8	-	-	PUNCT
cajgh-110	3	9	encapsulated	encapsulate	VERB
cajgh-110	3	10	forms	form	NOUN
cajgh-110	3	11	of	of	ADP
cajgh-110	3	12	erythropoietin	erythropoietin	ADJ
cajgh-110	3	13	zhanagul	zhanagul	PROPN
cajgh-110	3	14	khasenbekova1	khasenbekova1	PROPN
cajgh-110	3	15	,	,	PUNCT
cajgh-110	3	16	alexandr	alexandr	PROPN
cajgh-110	3	17	gulayev1	gulayev1	PROPN
cajgh-110	3	18	,	,	PUNCT
cajgh-110	3	19	elena	elena	PROPN
cajgh-110	3	20	nechayeva2	nechayeva2	PROPN
cajgh-110	3	21	,	,	PUNCT
cajgh-110	3	22	talgat	talgat	ADJ
cajgh-110	3	23	nurgozhin1	nurgozhin1	ADV
cajgh-110	3	24	,	,	PUNCT
cajgh-110	3	25	zhaxybay	zhaxybay	ADJ
cajgh-110	3	26	zhumadilov1	zhumadilov1	PROPN
cajgh-110	3	27	1center	1center	NUM
cajgh-110	3	28	for	for	ADP
cajgh-110	3	29	life	life	NOUN
cajgh-110	3	30	sciences	science	NOUN
cajgh-110	3	31	,	,	PUNCT
cajgh-110	3	32	nazarbayev	nazarbayev	ADJ
cajgh-110	3	33	university	university	NOUN
cajgh-110	3	34	2the	2the	PRON
cajgh-110	3	35	state	state	NOUN
cajgh-110	3	36	research	research	NOUN
cajgh-110	3	37	center	center	NOUN
cajgh-110	3	38	of	of	ADP
cajgh-110	3	39	virology	virology	NOUN
cajgh-110	3	40	and	and	CCONJ
cajgh-110	3	41	biotechnology	biotechnology	NOUN
cajgh-110	3	42	vector	vector	NOUN
cajgh-110	3	43	,	,	PUNCT
cajgh-110	3	44	novosibirsk	novosibirsk	PROPN
cajgh-110	3	45	,	,	PUNCT
cajgh-110	3	46	russia	russia	PROPN
cajgh-110	3	47	vol	vol	NOUN
cajgh-110	3	48	.	.	PROPN
cajgh-110	3	49	2	2	NUM
cajgh-110	3	50	,	,	PUNCT
cajgh-110	3	51	suppl	suppl	ADJ
cajgh-110	3	52	.	.	PUNCT
cajgh-110	4	1	(	(	PUNCT
cajgh-110	4	2	2013	2013	NUM
cajgh-110	4	3	)	)	PUNCT
cajgh-110	4	4	|	|	ADV
cajgh-110	4	5	issn	issn	VERB
cajgh-110	4	6	2166	2166	NUM
cajgh-110	4	7	-	-	SYM
cajgh-110	4	8	7403	7403	NUM
cajgh-110	4	9	(	(	PUNCT
cajgh-110	4	10	online	online	ADJ
cajgh-110	4	11	)	)	PUNCT
cajgh-110	4	12	doi	doi	NOUN
cajgh-110	4	13	10.5195	10.5195	NUM
cajgh-110	4	14	/	/	SYM
cajgh-110	4	15	cajgh.2013.110	cajgh.2013.110	PROPN
cajgh-110	4	16	|	|	NOUN
cajgh-110	4	17	http://cajgh.pitt.edu	http://cajgh.pitt.edu	VERB
cajgh-110	4	18	http://www.library.pitt.edu/	http://www.library.pitt.edu/	PROPN
cajgh-110	4	19	http://www.pitt.edu/	http://www.pitt.edu/	NOUN
cajgh-110	4	20	http://www.library.pitt.edu/articles/digpubtype/index.html	http://www.library.pitt.edu/articles/digpubtype/index.html	PUNCT
cajgh-110	5	1	http://www.upress.pitt.edu/upressindex.aspx	http://www.upress.pitt.edu/upressindex.aspx	PRON
cajgh-110	5	2	http://creativecommons.org/licenses/by/3.0/us/	http://creativecommons.org/licenses/by/3.0/us/	NOUN
cajgh-110	5	3	khasenbekova	khasenbekova	VERB
cajgh-110	5	4	this	this	DET
cajgh-110	5	5	work	work	NOUN
cajgh-110	5	6	is	be	AUX
cajgh-110	5	7	licensed	license	VERB
cajgh-110	5	8	under	under	ADP
cajgh-110	5	9	a	a	DET
cajgh-110	5	10	creative	creative	ADJ
cajgh-110	5	11	commons	common	NOUN
cajgh-110	5	12	attribution	attribution	NOUN
cajgh-110	5	13	3.0	3.0	NUM
cajgh-110	5	14	united	unite	VERB
cajgh-110	5	15	states	states	PROPN
cajgh-110	5	16	license	license	NOUN
cajgh-110	5	17	.	.	PUNCT
cajgh-110	6	1	this	this	DET
cajgh-110	6	2	journal	journal	NOUN
cajgh-110	6	3	is	be	AUX
cajgh-110	6	4	published	publish	VERB
cajgh-110	6	5	by	by	ADP
cajgh-110	6	6	theuniversity	theuniversity	NOUN
cajgh-110	6	7	library	library	NOUN
cajgh-110	6	8	system	system	NOUN
cajgh-110	6	9	of	of	ADP
cajgh-110	6	10	the	the	DET
cajgh-110	6	11	university	university	PROPN
cajgh-110	6	12	of	of	ADP
cajgh-110	6	13	pittsburgh	pittsburgh	PROPN
cajgh-110	6	14	as	as	ADP
cajgh-110	6	15	part	part	NOUN
cajgh-110	6	16	of	of	ADP
cajgh-110	6	17	its	its	PRON
cajgh-110	6	18	d	d	NOUN
cajgh-110	6	19	-	-	PUNCT
cajgh-110	6	20	scribe	scribe	VERB
cajgh-110	6	21	digital	digital	ADJ
cajgh-110	6	22	publishing	publishing	NOUN
cajgh-110	6	23	program	program	NOUN
cajgh-110	6	24	and	and	CCONJ
cajgh-110	6	25	is	be	AUX
cajgh-110	6	26	cosponsored	cosponsor	VERB
cajgh-110	6	27	by	by	ADP
cajgh-110	6	28	the	the	DET
cajgh-110	6	29	university	university	PROPN
cajgh-110	6	30	of	of	ADP
cajgh-110	6	31	pittsburgh	pittsburgh	PROPN
cajgh-110	6	32	press	press	NOUN
cajgh-110	6	33	.	.	PUNCT
cajgh-110	7	1	central	central	ADJ
cajgh-110	7	2	asian	asian	ADJ
cajgh-110	7	3	journal	journal	NOUN
cajgh-110	7	4	of	of	ADP
cajgh-110	7	5	global	global	ADJ
cajgh-110	7	6	health	health	NOUN
cajgh-110	7	7	volume	volume	NOUN
cajgh-110	7	8	2	2	NUM
cajgh-110	7	9	,	,	PUNCT
cajgh-110	7	10	suppl	suppl	ADJ
cajgh-110	7	11	.	.	PUNCT
cajgh-110	8	1	(	(	PUNCT
cajgh-110	8	2	2013	2013	NUM
cajgh-110	8	3	)	)	PUNCT
cajgh-110	8	4	|	|	ADV
cajgh-110	8	5	issn	issn	VERB
cajgh-110	8	6	2166	2166	NUM
cajgh-110	8	7	-	-	SYM
cajgh-110	8	8	7403	7403	NUM
cajgh-110	8	9	(	(	PUNCT
cajgh-110	8	10	online	online	ADJ
cajgh-110	8	11	)	)	PUNCT
cajgh-110	8	12	|	|	ADV
cajgh-110	8	13	doi	doi	X
cajgh-110	8	14	10.5195	10.5195	NUM
cajgh-110	8	15	/	/	SYM
cajgh-110	8	16	cajgh.2013.110	cajgh.2013.110	PROPN
cajgh-110	8	17	|	|	NOUN
cajgh-110	8	18	http://cajgh.pitt.edu	http://cajgh.pitt.edu	NOUN
cajgh-110	8	19	abstract	abstract	ADJ
cajgh-110	8	20	introduction	introduction	NOUN
cajgh-110	8	21	:	:	PUNCT
cajgh-110	8	22	the	the	DET
cajgh-110	8	23	recombinant	recombinant	ADJ
cajgh-110	8	24	human	human	ADJ
cajgh-110	8	25	erythropoietin	erythropoietin	NOUN
cajgh-110	8	26	(	(	PUNCT
cajgh-110	8	27	rhepo	rhepo	NOUN
cajgh-110	8	28	)	)	PUNCT
cajgh-110	8	29	is	be	AUX
cajgh-110	8	30	used	use	VERB
cajgh-110	8	31	in	in	ADP
cajgh-110	8	32	the	the	DET
cajgh-110	8	33	treatment	treatment	NOUN
cajgh-110	8	34	of	of	ADP
cajgh-110	8	35	anemia	anemia	NOUN
cajgh-110	8	36	.	.	PUNCT
cajgh-110	9	1	in	in	ADP
cajgh-110	9	2	order	order	NOUN
cajgh-110	9	3	to	to	PART
cajgh-110	9	4	improve	improve	VERB
cajgh-110	9	5	its	its	PRON
cajgh-110	9	6	pharmacokinetic	pharmacokinetic	ADJ
cajgh-110	9	7	properties	property	NOUN
cajgh-110	9	8	,	,	PUNCT
cajgh-110	9	9	nanoparticles	nanoparticle	NOUN
cajgh-110	9	10	of	of	ADP
cajgh-110	9	11	biodegradable	biodegradable	ADJ
cajgh-110	9	12	polymers	polymer	NOUN
cajgh-110	9	13	of	of	ADP
cajgh-110	9	14	natural	natural	ADJ
cajgh-110	9	15	or	or	CCONJ
cajgh-110	9	16	synthetic	synthetic	ADJ
cajgh-110	9	17	origin	origin	NOUN
cajgh-110	9	18	were	be	AUX
cajgh-110	9	19	used	use	VERB
cajgh-110	9	20	.	.	PUNCT
cajgh-110	10	1	the	the	DET
cajgh-110	10	2	aim	aim	NOUN
cajgh-110	10	3	of	of	ADP
cajgh-110	10	4	this	this	DET
cajgh-110	10	5	study	study	NOUN
cajgh-110	10	6	was	be	AUX
cajgh-110	10	7	to	to	PART
cajgh-110	10	8	investigate	investigate	VERB
cajgh-110	10	9	the	the	DET
cajgh-110	10	10	effect	effect	NOUN
cajgh-110	10	11	of	of	ADP
cajgh-110	10	12	new	new	ADJ
cajgh-110	10	13	nano	nano	NOUN
cajgh-110	10	14	-	-	PUNCT
cajgh-110	10	15	encapsulated	encapsulate	VERB
cajgh-110	10	16	forms	form	NOUN
cajgh-110	10	17	of	of	ADP
cajgh-110	10	18	recombinant	recombinant	ADJ
cajgh-110	10	19	human	human	ADJ
cajgh-110	10	20	erythropoietin	erythropoietin	NOUN
cajgh-110	10	21	for	for	ADP
cajgh-110	10	22	oral	oral	ADJ
cajgh-110	10	23	use	use	NOUN
cajgh-110	10	24	on	on	ADP
cajgh-110	10	25	the	the	DET
cajgh-110	10	26	erythropoiesis	erythropoiesis	NOUN
cajgh-110	10	27	in	in	ADP
cajgh-110	10	28	the	the	DET
cajgh-110	10	29	cyclophosphamide	cyclophosphamide	NOUN
cajgh-110	10	30	immunosuppression	immunosuppression	NOUN
cajgh-110	10	31	model	model	NOUN
cajgh-110	10	32	.	.	PUNCT
cajgh-110	11	1	material	material	NOUN
cajgh-110	11	2	and	and	CCONJ
cajgh-110	11	3	methods	method	NOUN
cajgh-110	11	4	:	:	PUNCT
cajgh-110	11	5	the	the	DET
cajgh-110	11	6	chope	chope	NOUN
cajgh-110	11	7	immortalized	immortalize	VERB
cajgh-110	11	8	cells	cell	NOUN
cajgh-110	11	9	culture	culture	NOUN
cajgh-110	11	10	(	(	PUNCT
cajgh-110	11	11	a	a	DET
cajgh-110	11	12	primary	primary	ADJ
cajgh-110	11	13	producer	producer	NOUN
cajgh-110	11	14	of	of	ADP
cajgh-110	11	15	rhepo	rhepo	NOUN
cajgh-110	11	16	"	"	PUNCT
cajgh-110	11	17	vector	vector	NOUN
cajgh-110	11	18	"	"	PUNCT
cajgh-110	11	19	in	in	ADP
cajgh-110	11	20	russia	russia	PROPN
cajgh-110	11	21	)	)	PUNCT
cajgh-110	11	22	was	be	AUX
cajgh-110	11	23	used	use	VERB
cajgh-110	11	24	.	.	PUNCT
cajgh-110	12	1	the	the	DET
cajgh-110	12	2	following	follow	VERB
cajgh-110	12	3	biodegradable	biodegradable	ADJ
cajgh-110	12	4	polymers	polymer	NOUN
cajgh-110	12	5	were	be	AUX
cajgh-110	12	6	chosen	choose	VERB
cajgh-110	12	7	:	:	PUNCT
cajgh-110	12	8	0.05	0.05	NUM
cajgh-110	12	9	%	%	NOUN
cajgh-110	12	10	and	and	CCONJ
cajgh-110	12	11	0.005	0.005	NUM
cajgh-110	12	12	%	%	NOUN
cajgh-110	12	13	carbopol	carbopol	NOUN
cajgh-110	12	14	,	,	PUNCT
cajgh-110	12	15	0.05	0.05	NUM
cajgh-110	12	16	%	%	NOUN
cajgh-110	12	17	and	and	CCONJ
cajgh-110	12	18	0.005	0.005	NUM
cajgh-110	12	19	%	%	NOUN
cajgh-110	12	20	kollidon	kollidon	NOUN
cajgh-110	12	21	,	,	PUNCT
cajgh-110	12	22	and	and	CCONJ
cajgh-110	12	23	0.05	0.05	NUM
cajgh-110	12	24	%	%	NOUN
cajgh-110	12	25	and	and	CCONJ
cajgh-110	12	26	0.005	0.005	NUM
cajgh-110	12	27	%	%	NOUN
cajgh-110	12	28	pectin	pectin	NOUN
cajgh-110	12	29	.	.	PUNCT
cajgh-110	13	1	immunosuppression	immunosuppression	NOUN
cajgh-110	13	2	was	be	AUX
cajgh-110	13	3	obtained	obtain	VERB
cajgh-110	13	4	by	by	ADP
cajgh-110	13	5	a	a	DET
cajgh-110	13	6	single	single	ADJ
cajgh-110	13	7	dose	dose	NOUN
cajgh-110	13	8	of	of	ADP
cajgh-110	13	9	i.p	i.p	PROPN
cajgh-110	13	10	.	.	PROPN
cajgh-110	13	11	injection	injection	NOUN
cajgh-110	13	12	of	of	ADP
cajgh-110	13	13	cyclophosphamide	cyclophosphamide	NOUN
cajgh-110	13	14	(	(	PUNCT
cajgh-110	13	15	250	250	NUM
cajgh-110	13	16	mg	mg	NUM
cajgh-110	13	17	/	/	SYM
cajgh-110	13	18	kg	kg	NOUN
cajgh-110	13	19	)	)	PUNCT
cajgh-110	13	20	in	in	ADP
cajgh-110	13	21	white	white	ADJ
cajgh-110	13	22	mice	mouse	NOUN
cajgh-110	13	23	(	(	PUNCT
cajgh-110	13	24	18	18	NUM
cajgh-110	13	25	-	-	SYM
cajgh-110	13	26	20	20	NUM
cajgh-110	13	27	g	g	NOUN
cajgh-110	13	28	)	)	PUNCT
cajgh-110	13	29	.	.	PUNCT
cajgh-110	14	1	during	during	ADP
cajgh-110	14	2	the	the	DET
cajgh-110	14	3	next	next	ADJ
cajgh-110	14	4	5	5	NUM
cajgh-110	14	5	days	day	NOUN
cajgh-110	14	6	,	,	PUNCT
cajgh-110	14	7	the	the	DET
cajgh-110	14	8	nano	nano	NOUN
cajgh-110	14	9	-	-	PUNCT
cajgh-110	14	10	encapsulated	encapsulate	VERB
cajgh-110	14	11	erythropoietin	erythropoietin	NOUN
cajgh-110	14	12	(	(	PUNCT
cajgh-110	14	13	100	100	NUM
cajgh-110	14	14	ed	ed	NOUN
cajgh-110	14	15	/	/	SYM
cajgh-110	14	16	mouse	mouse	NOUN
cajgh-110	14	17	)	)	PUNCT
cajgh-110	14	18	was	be	AUX
cajgh-110	14	19	administered	administer	VERB
cajgh-110	14	20	orally	orally	ADV
cajgh-110	14	21	to	to	ADP
cajgh-110	14	22	each	each	DET
cajgh-110	14	23	mouse	mouse	NOUN
cajgh-110	14	24	.	.	PUNCT
cajgh-110	15	1	after	after	ADP
cajgh-110	15	2	5	5	NUM
cajgh-110	15	3	and	and	CCONJ
cajgh-110	15	4	10	10	NUM
cajgh-110	15	5	days	day	NOUN
cajgh-110	15	6	,	,	PUNCT
cajgh-110	15	7	the	the	DET
cajgh-110	15	8	cell	cell	NOUN
cajgh-110	15	9	count	count	NOUN
cajgh-110	15	10	of	of	ADP
cajgh-110	15	11	the	the	DET
cajgh-110	15	12	number	number	NOUN
cajgh-110	15	13	of	of	ADP
cajgh-110	15	14	blood	blood	NOUN
cajgh-110	15	15	reticulocytes	reticulocyte	NOUN
cajgh-110	15	16	and	and	CCONJ
cajgh-110	15	17	the	the	DET
cajgh-110	15	18	myelogram	myelogram	NOUN
cajgh-110	15	19	of	of	ADP
cajgh-110	15	20	bone	bone	NOUN
cajgh-110	15	21	marrow	marrow	NOUN
cajgh-110	15	22	were	be	AUX
cajgh-110	15	23	performed	perform	VERB
cajgh-110	15	24	.	.	PUNCT
cajgh-110	16	1	the	the	DET
cajgh-110	16	2	control	control	PROPN
cajgh-110	16	3	group	group	NOUN
cajgh-110	16	4	of	of	ADP
cajgh-110	16	5	mice	mouse	NOUN
cajgh-110	16	6	received	receive	VERB
cajgh-110	16	7	injections	injection	NOUN
cajgh-110	16	8	of	of	ADP
cajgh-110	16	9	eprex	eprex	PROPN
cajgh-110	16	10	.	.	PUNCT
cajgh-110	17	1	results	result	NOUN
cajgh-110	17	2	:	:	PUNCT
cajgh-110	17	3	on	on	ADP
cajgh-110	17	4	the	the	DET
cajgh-110	17	5	5th	5th	ADJ
cajgh-110	17	6	day	day	NOUN
cajgh-110	17	7	of	of	ADP
cajgh-110	17	8	the	the	DET
cajgh-110	17	9	experiment	experiment	NOUN
cajgh-110	17	10	,	,	PUNCT
cajgh-110	17	11	the	the	DET
cajgh-110	17	12	highest	high	ADJ
cajgh-110	17	13	level	level	NOUN
cajgh-110	17	14	of	of	ADP
cajgh-110	17	15	reticulocyte	reticulocyte	NOUN
cajgh-110	17	16	was	be	AUX
cajgh-110	17	17	observed	observe	VERB
cajgh-110	17	18	in	in	ADP
cajgh-110	17	19	the	the	DET
cajgh-110	17	20	samples	sample	NOUN
cajgh-110	17	21	of	of	ADP
cajgh-110	17	22	erythropoietin	erythropoietin	NOUN
cajgh-110	17	23	with	with	ADP
cajgh-110	17	24	kollidon	kollidon	PROPN
cajgh-110	17	25	(	(	PUNCT
cajgh-110	17	26	0.05	0.05	NUM
cajgh-110	17	27	%	%	NOUN
cajgh-110	17	28	)	)	PUNCT
cajgh-110	17	29	and	and	CCONJ
cajgh-110	17	30	pectin	pectin	NOUN
cajgh-110	17	31	(	(	PUNCT
cajgh-110	17	32	0.005	0.005	NUM
cajgh-110	17	33	%	%	NOUN
cajgh-110	17	34	)	)	PUNCT
cajgh-110	17	35	nanoparticles	nanoparticle	NOUN
cajgh-110	17	36	.	.	PUNCT
cajgh-110	18	1	on	on	ADP
cajgh-110	18	2	the	the	DET
cajgh-110	18	3	10th	10th	ADJ
cajgh-110	18	4	day	day	NOUN
cajgh-110	18	5	,	,	PUNCT
cajgh-110	18	6	the	the	DET
cajgh-110	18	7	highest	high	ADJ
cajgh-110	18	8	activity	activity	NOUN
cajgh-110	18	9	was	be	AUX
cajgh-110	18	10	observed	observe	VERB
cajgh-110	18	11	in	in	ADP
cajgh-110	18	12	the	the	DET
cajgh-110	18	13	samples	sample	NOUN
cajgh-110	18	14	of	of	ADP
cajgh-110	18	15	erythropoietin	erythropoietin	ADJ
cajgh-110	18	16	substance	substance	NOUN
cajgh-110	18	17	with	with	ADP
cajgh-110	18	18	pectin	pectin	NOUN
cajgh-110	18	19	at	at	ADP
cajgh-110	18	20	0.05	0.05	NUM
cajgh-110	18	21	%	%	NOUN
cajgh-110	18	22	and	and	CCONJ
cajgh-110	18	23	0.005	0.005	NUM
cajgh-110	18	24	%	%	NOUN
cajgh-110	18	25	concentrations	concentration	NOUN
cajgh-110	18	26	.	.	PUNCT
cajgh-110	19	1	the	the	DET
cajgh-110	19	2	levels	level	NOUN
cajgh-110	19	3	of	of	ADP
cajgh-110	19	4	reticulocytes	reticulocyte	NOUN
cajgh-110	19	5	in	in	ADP
cajgh-110	19	6	these	these	DET
cajgh-110	19	7	groups	group	NOUN
cajgh-110	19	8	reached	reach	VERB
cajgh-110	19	9	13.53	13.53	NUM
cajgh-110	19	10	%	%	NOUN
cajgh-110	19	11	and	and	CCONJ
cajgh-110	19	12	14.55	14.55	NUM
cajgh-110	19	13	%	%	NOUN
cajgh-110	19	14	,	,	PUNCT
cajgh-110	19	15	respectively	respectively	ADV
cajgh-110	19	16	.	.	PUNCT
cajgh-110	20	1	the	the	DET
cajgh-110	20	2	results	result	NOUN
cajgh-110	20	3	of	of	ADP
cajgh-110	20	4	the	the	DET
cajgh-110	20	5	myelogram	myelogram	NOUN
cajgh-110	20	6	during	during	ADP
cajgh-110	20	7	immunosuppression	immunosuppression	NOUN
cajgh-110	20	8	showed	show	VERB
cajgh-110	20	9	some	some	DET
cajgh-110	20	10	activity	activity	NOUN
cajgh-110	20	11	of	of	ADP
cajgh-110	20	12	erythropoietin	erythropoietin	NOUN
cajgh-110	20	13	in	in	ADP
cajgh-110	20	14	conjunction	conjunction	NOUN
cajgh-110	20	15	with	with	ADP
cajgh-110	20	16	both	both	DET
cajgh-110	20	17	concentrations	concentration	NOUN
cajgh-110	20	18	of	of	ADP
cajgh-110	20	19	pectin	pectin	NOUN
cajgh-110	20	20	when	when	SCONJ
cajgh-110	20	21	a	a	DET
cajgh-110	20	22	two	two	NUM
cajgh-110	20	23	-	-	ADJ
cajgh-110	20	24	fold	fold	ADJ
cajgh-110	20	25	increase	increase	NOUN
cajgh-110	20	26	in	in	ADP
cajgh-110	20	27	the	the	DET
cajgh-110	20	28	number	number	NOUN
cajgh-110	20	29	of	of	ADP
cajgh-110	20	30	erythroblasts	erythroblast	NOUN
cajgh-110	20	31	was	be	AUX
cajgh-110	20	32	observed	observe	VERB
cajgh-110	20	33	on	on	ADP
cajgh-110	20	34	the	the	DET
cajgh-110	20	35	5th	5th	ADJ
cajgh-110	20	36	day	day	NOUN
cajgh-110	20	37	.	.	PUNCT
cajgh-110	21	1	high	high	ADJ
cajgh-110	21	2	degrees	degree	NOUN
cajgh-110	21	3	of	of	ADP
cajgh-110	21	4	erythrokaryocytes	erythrokaryocyte	NOUN
cajgh-110	21	5	in	in	ADP
cajgh-110	21	6	the	the	DET
cajgh-110	21	7	state	state	NOUN
cajgh-110	21	8	of	of	ADP
cajgh-110	21	9	mitosis	mitosis	NOUN
cajgh-110	21	10	were	be	AUX
cajgh-110	21	11	observed	observe	VERB
cajgh-110	21	12	in	in	ADP
cajgh-110	21	13	the	the	DET
cajgh-110	21	14	0.05	0.05	NUM
cajgh-110	21	15	%	%	NOUN
cajgh-110	21	16	pectin	pectin	NOUN
cajgh-110	21	17	samples	sample	NOUN
cajgh-110	21	18	.	.	PUNCT
cajgh-110	22	1	similar	similar	ADJ
cajgh-110	22	2	results	result	NOUN
cajgh-110	22	3	were	be	AUX
cajgh-110	22	4	observed	observe	VERB
cajgh-110	22	5	in	in	ADP
cajgh-110	22	6	equivalent	equivalent	ADJ
cajgh-110	22	7	groups	group	NOUN
cajgh-110	22	8	of	of	ADP
cajgh-110	22	9	control	control	NOUN
cajgh-110	22	10	animals	animal	NOUN
cajgh-110	22	11	on	on	ADP
cajgh-110	22	12	the	the	DET
cajgh-110	22	13	10th	10th	ADJ
cajgh-110	22	14	day	day	NOUN
cajgh-110	22	15	of	of	ADP
cajgh-110	22	16	the	the	DET
cajgh-110	22	17	experiment	experiment	NOUN
cajgh-110	22	18	,	,	PUNCT
cajgh-110	22	19	which	which	PRON
cajgh-110	22	20	is	be	AUX
cajgh-110	22	21	compatible	compatible	ADJ
cajgh-110	22	22	with	with	ADP
cajgh-110	22	23	the	the	DET
cajgh-110	22	24	data	datum	NOUN
cajgh-110	22	25	on	on	ADP
cajgh-110	22	26	eprex	eprex	ADJ
cajgh-110	22	27	action	action	NOUN
cajgh-110	22	28	.	.	PUNCT
cajgh-110	23	1	conclusion	conclusion	NOUN
cajgh-110	23	2	:	:	PUNCT
cajgh-110	23	3	the	the	DET
cajgh-110	23	4	erythropoietic	erythropoietic	ADJ
cajgh-110	23	5	activity	activity	NOUN
cajgh-110	23	6	of	of	ADP
cajgh-110	23	7	nano	nano	NOUN
cajgh-110	23	8	-	-	PUNCT
cajgh-110	23	9	encapsulated	encapsulate	VERB
cajgh-110	23	10	forms	form	NOUN
cajgh-110	23	11	of	of	ADP
cajgh-110	23	12	erythropoietin	erythropoietin	NOUN
cajgh-110	23	13	was	be	AUX
cajgh-110	23	14	observed	observe	VERB
cajgh-110	23	15	in	in	ADP
cajgh-110	23	16	the	the	DET
cajgh-110	23	17	0.05	0.05	NUM
cajgh-110	23	18	%	%	NOUN
cajgh-110	23	19	and	and	CCONJ
cajgh-110	23	20	0.005	0.005	NUM
cajgh-110	23	21	%	%	NOUN
cajgh-110	23	22	pectin	pectin	NOUN
cajgh-110	23	23	samples	sample	NOUN
cajgh-110	23	24	in	in	ADP
cajgh-110	23	25	the	the	DET
cajgh-110	23	26	cyclophosphamide	cyclophosphamide	NOUN
cajgh-110	23	27	immunosuppression	immunosuppression	NOUN
cajgh-110	23	28	model	model	NOUN
cajgh-110	23	29	setting	setting	NOUN
cajgh-110	23	30	.	.	PUNCT
cajgh-110	24	1	keywords	keyword	NOUN
cajgh-110	24	2	:	:	PUNCT
cajgh-110	24	3	erythropoiesis	erythropoiesis	NOUN
cajgh-110	24	4	,	,	PUNCT
cajgh-110	24	5	nanobiotechnology	nanobiotechnology	NOUN
cajgh-110	24	6	,	,	PUNCT
cajgh-110	24	7	recombinant	recombinant	ADJ
cajgh-110	24	8	human	human	ADJ
cajgh-110	24	9	erythropoietin	erythropoietin	NOUN
cajgh-110	24	10	http://www.library.pitt.edu/	http://www.library.pitt.edu/	PROPN
cajgh-110	24	11	http://www.pitt.edu/	http://www.pitt.edu/	NOUN
cajgh-110	24	12	http://www.library.pitt.edu/articles/digpubtype/index.html	http://www.library.pitt.edu/articles/digpubtype/index.html	X
cajgh-110	24	13	http://www.upress.pitt.edu/upressindex.aspx	http://www.upress.pitt.edu/upressindex.aspx	NOUN